PointState Capital LP boosted its holdings in shares of Aetna (NYSE:AET) by 136.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,038,244 shares of the company’s stock after purchasing an additional 599,724 shares during the period. Aetna comprises 1.9% of PointState Capital LP’s portfolio, making the stock its 14th biggest holding. PointState Capital LP owned about 0.32% of Aetna worth $175,463,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Cornerstone Advisors Inc. grew its holdings in Aetna by 263.6% during the 1st quarter. Cornerstone Advisors Inc. now owns 600 shares of the company’s stock worth $101,000 after acquiring an additional 435 shares during the period. Focused Wealth Management Inc raised its holdings in shares of Aetna by 84.5% in the 4th quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock valued at $118,000 after purchasing an additional 300 shares during the period. Bruderman Asset Management LLC bought a new stake in shares of Aetna in the 1st quarter valued at about $118,000. Centaurus Financial Inc. acquired a new position in Aetna in the 1st quarter valued at about $128,000. Finally, Clearwater Capital Advisors LLC acquired a new position in Aetna in the 1st quarter valued at about $154,000. Hedge funds and other institutional investors own 84.93% of the company’s stock.
Shares of NYSE AET opened at $183.50 on Friday. The firm has a market capitalization of $60.63 billion, a price-to-earnings ratio of 18.61, a P/E/G ratio of 1.56 and a beta of 0.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.73. Aetna has a 12 month low of $149.69 and a 12 month high of $194.40.
Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.97 by $0.22. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The company had revenue of $15.34 billion for the quarter, compared to the consensus estimate of $15.32 billion. During the same period in the prior year, the firm posted $2.71 EPS. Aetna’s revenue for the quarter was up 1.1% on a year-over-year basis. equities research analysts expect that Aetna will post 11.06 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 1st. Shareholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Tuesday, July 24th. Aetna’s payout ratio is 20.28%.
A number of research analysts have issued reports on AET shares. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday. Cantor Fitzgerald raised shares of Aetna from a “neutral” rating to an “overweight” rating in a research note on Tuesday, May 1st. Zacks Investment Research raised shares of Aetna from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Finally, Credit Suisse Group decreased their price objective on shares of Aetna from $208.00 to $194.00 and set a “neutral” rating for the company in a research report on Monday, May 14th. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $196.36.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.